The Company continues working with the third-party manufacturer to address recent FDA follow-up information requests which are required to lift the clinical hold concerning the nebulizer device used ...
Summary • BiomX Inc. (PHGE) stock fell 13% in pre-market trading, dropping to $5.00 from $5.78.• The decline follows an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback